Chugai Pharmaceutical Co., Ltd. (TYO:4519)

Japan flag Japan · Delayed Price · Currency is JPY
8,620.00
+181.00 (2.14%)
May 2, 2025, 3:30 PM JST
71.51%
Market Cap 14.19T
Revenue (ttm) 1.22T
Net Income (ttm) 410.15B
Shares Out 1.65B
EPS (ttm) 249.23
PE Ratio 34.59
Forward PE 32.47
Dividend 100.00 (1.16%)
Ex-Dividend Date Jun 27, 2025
Volume 4,157,300
Average Volume 3,209,675
Open 8,456.00
Previous Close 8,439.00
Day's Range 8,341.00 - 8,655.00
52-Week Range 4,572.00 - 8,655.00
Beta 0.76
RSI 70.16
Earnings Date Apr 24, 2025

About Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Perjeta, Polivy, Tecentriq, and Phesgo; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept for immunosuppressant; Edirol, an osteoporosis agent; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrys... [Read more]

Sector Healthcare
Founded 1925
Employees 5,026
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4519
Full Company Profile

Financial Performance

In 2024, Chugai Pharmaceutical's revenue was 1.17 trillion, an increase of 5.33% compared to the previous year's 1.11 trillion. Earnings were 387.32 billion, an increase of 19.00%.

Financial Statements

News

Japanese Stocks Close Lower Amid Global Trade Tensions

Japanese stocks ended lower as growing U.S.-China trade tensions weighed on the global economic outlook. Electronics, pharmaceutical and auto shares led the losses. Sony Group dropped 7.4%, Chugai Pha...

25 days ago - Barron's

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q4 2024 Earnings Conference Call January 30, 2025 3:30 AM ETCompany ParticipantsKae Miyata - Head of Corporate...

3 months ago - Seeking Alpha

Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript

Full Year 2024 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript

3 months ago - GuruFocus

Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market

Roche Holding AG (OTC: RHHBY) reportedly turned down a potential blockbuster weight-loss pill in 2018, allowing Eli Lilly And Co (NYSE: LLY) to acquire the drug, now known as orforglipron, for just ...

9 months ago - Benzinga

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2024 Earnings Conference Call July 24, 2024 4:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and C...

10 months ago - Seeking Alpha

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Call Transcript

Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ET

1 year ago - Seeking Alpha